135 related articles for article (PubMed ID: 26770686)
1. A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients.
Eldemiry EM; Sabry NA; Abbassi MM; Abdel Shafy SS; Mokhtar MS; Abdel Bary A
SAGE Open Med; 2013; 1():2050312113507921. PubMed ID: 26770686
[TBL] [Abstract][Full Text] [Related]
2. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
5. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
6. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
8. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
9. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
11. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
13. Development of a model to predict vancomycin serum concentration during continuous infusion of vancomycin in critically ill pediatric patients.
Han YJ; Jang W; Kim JS; Kim HJ; Suh SY; Cho YS; Park JD; Lee B
Korean J Physiol Pharmacol; 2024 Mar; 28(2):121-127. PubMed ID: 38414395
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin dosing for pneumonia in critically ill trauma patients.
Patanwala AE; Norris CJ; Nix DE; Kopp BJ; Erstad BL
J Trauma; 2009 Oct; 67(4):802-4. PubMed ID: 19820588
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
Moffett BS; Morris J; Munoz F; Arikan AA
Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
[TBL] [Abstract][Full Text] [Related]
16. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
James JK; Palmer SM; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection.
Di Filippo A; De Gaudio AR; Novelli A; Paternostro E; Pelagatti C; Livi P; Novelli GP
Chemotherapy; 1998; 44(1):63-8. PubMed ID: 9444411
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
Fung L
Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients.
Spapen HD; Janssen van Doorn K; Diltoer M; Verbrugghe W; Jacobs R; Dobbeleir N; Honoré PM; Jorens PG
Ann Intensive Care; 2011 Jul; 1(1):26. PubMed ID: 21906376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
